Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors

被引：32
作者：
Abdallah, Abdallah E. [1 ]
Mabrouk, Reda R. [1 ]
Al Ward, Maged Mohammed Saleh [1 ]
Eissa, Sally, I [2 ,3 ]
Elkaeed, Eslam B. [3 ]
Mehany, Ahmed B. M. [4 ]
Abo-Saif, Mariam A. [5 ]
El-Feky, Ola A. [5 ]
Alesawy, Mohamed S. [1 ]
El-Zahabi, Mohamed Ayman [1 ]
机构：
[1] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo, Egypt
[2] Al Azhar Univ, Fac Pharm Girls, Dept Pharmaceut Chem, Cairo, Egypt
[3] AlMaarefa Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh, Saudi Arabia
[4] Al Azhar Univ, Fac Sci, Zool Dept, Cairo, Egypt
[5] Tanta Univ, Fac Pharm, Biochem Dept, Tanta, Egypt
来源：
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2022年 / 37卷 / 01期
关键词：
Anticancer; apoptosis; multi-kinase; pharmacophoric features; VEGFR-2; KINASE INHIBITORS; DISCOVERY; CANCER; DERIVATIVES; MECHANISMS; BINDING;
D O I：
10.1080/14756366.2021.2017911
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Based on quinazoline, quinoxaline, and nitrobenzene scaffolds and on pharmacophoric features of VEGFR-2 inhibitors, 17 novel compounds were designed and synthesised. VEGFR-2 IC50 values ranged from 60.00 to 123.85 nM for the new derivatives compared to 54.00 nM for sorafenib. Compounds 15(a) , 15(b) , and 15(d) showed IC50 from 17.39 to 47.10 mu M against human cancer cell lines; hepatocellular carcinoma (HepG2), prostate cancer (PC3), and breast cancer (MCF-7). Meanwhile, the first in terms of VEGFR-2 inhibition was compound 15(d) which came second with regard to antitumor assay with IC50 = 24.10, 40.90, and 33.40 mu M against aforementioned cell lines, respectively. Furthermore, Compound 15(d) increased apoptosis rate of HepG2 from 1.20 to 12.46% as it significantly increased levels of Caspase-3, BAX, and P53 from 49.6274, 40.62, and 42.84 to 561.427, 395.04, and 415.027 pg/mL, respectively. Moreover, 15(d) showed IC50 of 253 and 381 nM against HER2 and FGFR, respectively.
引用
收藏
页码：573 / 591
页数：19
相关论文
共 50 条
[41]   Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives [J].
Alkamaly, Omkulthom M. ;
Altwaijry, Najla ;
Sabour, Rehab ;
Harras, Marwa F. .
ARCHIV DER PHARMAZIE, 2021, 354 (04)
[42]   Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents [J].
Roaiah, Hanaa M. ;
Ghannam, Iman A. Y. ;
Ali, Islam H. ;
El Kerdawy, Ahmed M. ;
Ali, Mamdouh M. ;
Abbas, Safinaz E-S. ;
El-Nakkady, Sally S. .
ARCHIV DER PHARMAZIE, 2018, 351 (02)
[43]   Synthesis of thiazoloquinolinone derivatives: molecular docking, MD simulation, and pharmacological evaluation as VEGFR-2 inhibitors [J].
Amiri, Zeinab ;
Bayat, Mohammad ;
Gheidari, Davood .
BMC CHEMISTRY, 2025, 19 (01)
[44]   Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors [J].
El-Helby, Abdel-Ghany A. ;
Sakr, Helmy ;
Eissa, Ibrahim H. ;
Abulkhair, Hamada ;
Al-Karmalawy, Ahmed A. ;
El-Adl, Khaled .
ARCHIV DER PHARMAZIE, 2019, 352 (10)
[45]   New fluorinated diarylureas linked to pyrrolo[2,3-d]pyrimidine scaffold as VEGFR-2 inhibitors: Molecular docking and biological evaluation [J].
Adel, Mai ;
Abouzid, Khaled A. M. .
BIOORGANIC CHEMISTRY, 2022, 127
[46]   Selective VEGFR-2 inhibitors: Synthesis of pyridine derivatives, cytotoxicity and apoptosis induction profiling [J].
AbdelHaleem, Amal ;
Mansour, Amira O. ;
AbdelKader, Marwa ;
Arafa, Reem K. .
BIOORGANIC CHEMISTRY, 2020, 103
[47]   Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors [J].
Zengin, Merve ;
Tan, Oya Unsal ;
Arafa, Reem ;
Balkan, Ayla .
BIOORGANIC CHEMISTRY, 2022, 121
[48]   Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors [J].
Zeidan, Mohamed A. ;
Mostafa, Amany S. ;
Gomaa, Rania M. ;
Abou-zeid, Laila A. ;
El-Mesery, Mohamed ;
El-Sayed, Magda A. -A. ;
Selim, Khalid B. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 168 :315-329
[49]   Targeting VEGFR-2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies [J].
Alsaif, Nawaf A. ;
Mahdy, Hazem A. ;
Alanazi, Mohammed M. ;
Obaidullah, Ahmad J. ;
Alkahtani, Hamad M. ;
Al-Hossaini, Abdullah M. ;
Al-Mehizi, Abdulrahman A. ;
Elwan, Alaa ;
Taghour, Mohammed S. .
ARCHIV DER PHARMAZIE, 2022, 355 (02)
[50]   In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers [J].
Abdelnaby, Rana M. ;
El-Malah, Afaf A. ;
FakhrEldeen, Rasha R. ;
Saeed, Marwa M. ;
Nadeem, Rania, I ;
Younis, Nancy S. ;
Abdel-Rahman, Hanaa M. ;
El-Dydamony, Nehad M. .
PHARMACEUTICALS, 2022, 15 (06)
12345